Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Link to SEPIO compliant JSON-LD document

Variant: NM_000545.6(HNF1A):c.1501+1G>A

CA386970409

430837 (ClinVar)

Gene: HNF1A

Condition: monogenic diabetes

Inheritance Mode: Autosomal dominant inheritance

Link to MONDO

UUID: c5cc6716-ae85-43d2-855d-a1031a3b4091

Approved on: 2022-04-17

Published on: 2022-04-17

HGVS expressions

NM_000545.6:c.1501+1G>A

NM_000545.6(HNF1A):c.1501+1G>A

NC_000012.12:g.120997666G>A

CM000674.2:g.120997666G>A

NC_000012.11:g.121435469G>A

CM000674.1:g.121435469G>A

NC_000012.10:g.119919852G>A

NG_011731.2:g.23921G>A

ENST00000257555.11:c.1501+1G>A

ENST00000257555.10:c.1501+1G>A

ENST00000400024.6:c.1502G>A

ENST00000402929.5:n.2368G>A

ENST00000535955.5:n.218G>A

ENST00000538626.2:n.366G>A

ENST00000538646.5:c.*478G>A

ENST00000540108.1:c.*941+1G>A

ENST00000541395.5:c.1501+1G>A

ENST00000541924.5:c.*516G>A

ENST00000543255.1:n.546G>A

ENST00000543427.5:c.964+1G>A

ENST00000544413.2:c.1501+1G>A

ENST00000544574.5:c.*265G>A

ENST00000560968.5:n.1318+1G>A

ENST00000615446.4:c.289+1G>A

ENST00000617366.4:c.618+1G>A

NM_000545.5:c.1501+1G>A

NM_001306179.1:c.1501+1G>A

NM_000545.8:c.1501+1G>A

NM_001306179.2:c.1501+1G>A

NM_000545.8(HNF1A):c.1501+1G>A

Likely Pathogenic

The Expert Panel has overridden the computationally generated classification - "Uncertain Significance - Insufficient Evidence"

PVS1 PM2_Supporting

PS1

Evidence Links 0

Expert Panel

Monogenic Diabetes VCEP

Criteria Specification Information

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Monogenic Diabetes VCEP

The c.1501+1G>A variant in the HNF1 homeobox A gene, HNF1A, is predicted to remove a canonical splice donor site in intron 7 of NM_000545.8. This variant is predicted to cause an in-frame deletion of biologically-relevant exon 7 of 10, removing more than 18% of the transactivation domain, a region important for protein function (PVS1; PMID: 23348805). Additionally, this variant is absent from gnomAD v2.1.1 (PM2_Supporting). The nucleotide change, c.1501+1G>T, which causes the same splice donor loss, has been reported in a patient with monogenic diabetes; however, the c.1501+1G>T variant has not met the criteria to be classified as pathogenic for monogenic diabetes by the ClinGen MDEP. In summary, c.1501+1G>A meets the criteria to be classified as likely pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP VCEP (specification version 1.1, approved 9/30/2021): PVS1, PM2_Supporting. 

PVS1

This variant is predicted to cause an in-frame deletion of biologically-relevant exon 7 of 10, removing more than 18% of the transactivation domain, a region important for protein function (PMID: 23348805).

PM2_Supporting

This variant is absent from gnomAD.

PS1

The nucleotide change, c.1501+1G>T, which causes the same splice donor loss, has been reported in a patient with monogenic diabetes; however, the c.1501+1G>T variant has not met the criteria to be classified as pathogenic for monogenic diabetes by the ClinGen MDEP.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.